Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas H Keller
CGH2466, a Combined Adenosine Receptor Antagonist, P38 Mitogen-Activated Protein Kinase and Phosphodiesterase Type 4 Inhibitor With Potentin Vitroandin Vivoanti-Inflammatory Activities
British Journal of Pharmacology
Pharmacology
Related publications
LY2228820 Dimesylate, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formationin Vitroandin Vivo
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)
Science-Business eXchange
P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)
Science-Business eXchange
Metabolism of a Novel Skepinone L-Like P38 Mitogen-Activated Protein Kinase Inhibitor
MedChemComm
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Pharmaceutical Science
Drug Discovery
Human P38 Mitogen-Activated Protein Kinase Inhibitor Drugs Inhibit Plasmodium Falciparum Replication
Experimental Parasitology
Medicine
Parasitology
Infectious Diseases
Immunology
MAP2K4 (Mitogen-Activated Protein Kinase Kinase 4)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Activation of P38 Mitogen-Activated Protein Kinase Promotes Epidermal Growth Factor Receptor Internalization
Traffic
Biochemistry
Genetics
Cell Biology
Molecular Biology
Structural Biology
P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14); X-Box Binding Protein 1 (XBP1)
Science-Business eXchange
Cutaneous P38 Mitogen-Activated Protein Kinase Activation Triggers Psoriatic Dermatitis
Journal of Allergy and Clinical Immunology
Allergy
Immunology
